ERK signatures.xlsx

syn64925843

Created By Jiawan Wang jwang255

studyId: syn53604892
studyName: Advancing RAS pathway targeted therapy in NF1-MPNST - effects of SHP2 and CDK4 or CDK6 inhibitors on the tumor and the tumor immune microenvironment
initiative: Other
fundingAgency: Other

ERK signatures.xlsx page is loading…